Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.88B |
| Enterprise Value | 3.69B |
| P/E Ratio | 26.12 |
| PEG Ratio | -0.49 |
| Price/Sales Ratio | 4.19 |
| Price/Book Ratio | 1.13 |
| Enterprise/Revenue | 4.15 |
| Enterprise/EBITDA | 14.43 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.17 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 563.14M |
| Revenue/Share | 2.57 |
| Gross Profit | 574.88M |
| EBITDA | 203.16M |
| Net Income | 143.72M |
| Diluted EPS | 0.86 |
Balance Sheet
| Total Cash | 386.85M |
| Total Cash/Share | 2.31 |
| Total Debt | 206.67M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 3.76 |
| Book Value Per Share | 9.53 |
Price History
| 52-Week Change | -57.6 |
| 52-Week High | 31.13 |
| 52-Week Low | 10.3 |
| Moving Average 50 Days | 13.02 |
| Moving Average 200 Days | 19.22 |
Statistics
| Average Volume | 3.48M |
| Shares Outstanding | 168.31M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.2 |
| Trailing Annual Dividend Yield | 1.88 |
| Payout Ratio | 0.04 |
| Last Split Factor | 7:5 |
| Last Split Date | July 18, 2023 |
AD
